Trump has frozen all travel and communications at the Department of Health and Human Services, including the CDC and the National Institutes of Health

The Trump administration continues its deluge of executive orders that directly affect science and research, just days after being sworn in. Following the executive orders (EOs) taking the United States out of the Paris Agreement and World Health Organization and the scientific nonsense in the EO on trans and non-binary people,

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

Despite concerns about the future of research at the National Institutes of Health, current clinical trials can continue as scheduled, the agency’s acting director told staff scientists in an email Monday.